Organon (OGN) Misses Q4 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Organon & Co. (OGN) PT Lowered to $19 at Goldman Sachs
February 14, 2025 11:58 AM ESTGoldman Sachs analyst Chris Shibutani lowered the price target on Organon & Co. (NYSE: OGN) to $19.00 (from $20.00) while maintaining a Neutral rating.
The analyst comments "OGN shares outperformed (+11% vs. +1% SPX on the day) in the context of 4Q24 results that were generally in line with expectations overall. FY2025 guidance - that actually came in slightly... More
